Form 6-K China Nepstar Chain Drug For: May 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
China Nepstar Chain Drugstore (NPD) Reports Q1 EPS of $0.08; Comps Rose 9.8%
May 31, 2016 6:24 AM EDTChina Nepstar Chain Drugstore (NYSE: NPD) reported Q1 EPS of $0.08, versus $0.03 reported last year. Revenue for the quarter came in at $834.3 million, versus $759.1 million reported last year.
Same store sales increased by 9.8% compared to the first quarter of 2015
For earnings history and... More
